Prevention of cardiovascular disease: Why do we neglect the most potent intervention?

Heart

Volumn 96, Issue 4, 2010, Pages 261-262

  Stamatakis, Emmanuel ^a   Weiler, Richard ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Centre for Sports and Exercise Medicine   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; HEART PROTECTION; HUMAN; LIFESTYLE MODIFICATION; LONG TERM CARE; PHYSICAL ACTIVITY; PRESCRIPTION; PREVENTIVE MEDICINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SHORT SURVEY;

CARDIOVASCULAR DISEASES; HUMANS; MOTOR ACTIVITY;

EID: 77649147792     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.186593     Document Type: Short Survey

References (12)

1. Warburton DER, Katzmarzyk PT, Rhodes RE, et al. Evidence-informed physical activity guidelines fair Canadian adults. Appl Physiol Nutr Metab 2007;32:S16-68.
2. Grundy SM, Scott M. Primary prevention of coronary heart disease. Circulation 1999;100:988-98.
3. Wright JA. Are lipid-lowering guidelines evidence-based? Lancet 2007;369:168-9.
4. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665.
5. Byberg L, Melhus H, Gedeborg R, et al. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med 2009;43:482.
6. Ornish D. Statins and the soul of medicine. Am J Cardiol 2002;89:1286-90.
7. Marcus BH, Williams DM, Dubbert PM, et al. Physical activity intervention studies: what we know and what we need to know: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); Council on Cardiovascular Disease in the Young; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation 2006;114:2739-52.
8. Oxford handbook of general practice. Compliance. Oxford: Oxford Handbooks, 94-95.
9. Gupta K, Fan L. Doctors: fighting fit or couch potatoes? Br J Sports Med 2009;43:153-4.
10. Greenland P. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians. Arch Intern Med 2009;169:829-31.
11. Mitka M. Lifestyle modification and heart disease. Researchers not deterred by trials show no benefit. JAMA 2009;301:150-1.
12. Stamatakis E, Hamer M, Primatesta P. Cardiovascular medication, physical activity and mortality: cross-sectional population study with ongoing mortality follow-up. Heart 2009;95:448-53.